Monocytes and granulocytes reduce CD38 expression levels on myeloma cells in patients treated with daratumumab

PURPOSE: Daratumumab treatment results in a marked reduction of CD38 expression on multiple myeloma (MM) cells. The aim of this study was to investigate the clinical implications and the underlying mechanisms of daratumumab-mediated CD38 reduction. EXPERIMENTAL DESIGN: We evaluated the effect of dar...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Krejcik, Jakub, Frerichs, Kris A., Nijhof, Inger S., van Kessel, Berris, van Velzen, Jeroen F., Bloem, Andries C., Broekmans, Marloes E.C., Zweegman, Sonja, van Meerloo, Johan, Musters, René J.P., Poddighe, Pino J., Groen, Richard W.J., Chiu, Christopher, Plesner, Torben, Lokhorst, Henk M., Sasser, A. Kate, Mutis, Tuna, van de Donk, Niels W.C.J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5732844/
https://ncbi.nlm.nih.gov/pubmed/29025767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-17-2027
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados